Quick Answer
Polaryx Therapeutics, Inc. reported Stockholders Equity of $4.57 million for fiscal year 2025.
Polaryx Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.57M | -3.1% |
| 2024 | $4.71M | +269.0% |
| 2023 | $1.28M | — |
- Polaryx Therapeutics, Inc. showed a decrease of -3.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, Polaryx Therapeutics, Inc.’s stockholders equity has grown by 257.5% (from $1.28 million to $4.57 million).
- The most recent figure is from Polaryx Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: